DUBLIN–(BUSINESS WIRE)–The “Mice Model Market – Global Forecast 2025-2032” has been added to ResearchAndMarkets.com’s offering.
The mice model market is experiencing robust growth, with projected expansion from USD 1.61 billion in 2024 to USD 3.11 billion by 2032, driven by a compound annual growth rate (CAGR) of 8.60%. This market research report explores the pioneering advances, critical drivers, and significant innovations redefining the landscape of mice model research, particularly in the realms of oncology, neuroscience, immunology, and rare diseases. Research organizations are leveraging cutting-edge genetic engineering and high-throughput technologies to address complex challenges in translational relevance and reproducibility.
Transformative Developments in Mice Model Research
Significant advancements in gene editing technologies, such as CRISPR/Cas9, have transformed the scientific community’s approach to using mice models. Innovations in phenotyping and imaging are enhancing data granularity, improving the translational correlation of preclinical models. As institutions reengineer workflows for efficiency, collaborative ventures have emerged, enabling rapid translation of discoveries into therapeutic modalities. Through these developments, decision-makers can refine strategic planning and gain a competitive edge in biomedical research.
Key Takeaways from This Report
- Genetic Engineering Innovations: Technologies such as CRISPR/Cas9 have democratized access to precise genomic modifications, fostering personalized medicine and rapid target validation.
- Tariff Implications: U.S. tariffs have reshaped sourcing strategies, pushing for domestic breeding and collaboration to ensure supply chain resilience.
- Segmentation Opportunities: Diverse model types and end-user profiles offer strategic investment opportunities in fields like oncology, genetic disorders, and immunology.
- Regional Dynamics: Accelerating R&D budgets in the Asia-Pacific region and robust biotechnology hubs in the Americas drive regional growth, while collaborative frameworks in Europe ensure high research standards.
Key Segmentation Insights
The mice model ecosystem is segmented into various model types, applications, and end-users, offering insight into market opportunities:
- Model Types: Genetically engineered models, including conditional knockout, humanized, knockout, and transgenic models, are driving high-value research areas.
- Applications: Mice models play key roles in behavioral studies, cardiovascular diseases, drug discovery, genetic research, and more, supporting competitive market positioning.
- End Users: Academic institutions, CROs, hospitals, and biopharmaceutical companies each exhibit distinct demands, highlighting areas for targeted collaboration.
Regional Dynamics and Growth Drivers
Growth across various regions significantly influences mice model research:
- Americas: Established biotech hubs and robust funding ecosystems provide a strong foundation for collaboration between academia and industry.
- EMEA: Centralized regulatory protocols and emerging research centers foster cross-border partnerships and scientific capacity building.
- Asia-Pacific: Expanding R&D budgets and biotech clusters create fertile grounds for growth, supporting strategic planning and market entry.
Strategic Recommendations
To navigate the dynamic landscape, industry leaders should diversify breeding operations, invest in automation and data analytics, and foster cross-sector alliances. These strategies will enhance operational efficiency, drive innovation, and support long-term strategic positioning.
Key Attributes
| Report Attribute | Details |
| No. of Pages | 185 |
| Forecast Period | 2025-2032 |
| Estimated Market Value (USD) in 2025 | $1.74 Billion |
| Forecasted Market Value (USD) by 2032 | $3.11 Billion |
| Compound Annual Growth Rate | 8.6% |
| Regions Covered | Global |
Market Insights
- Expansion of humanized mouse models to improve immuno-oncology therapeutic testing and translational accuracy
- Adoption of 3D bioprinted mouse organoids to enhance preclinical drug safety and toxicity studies
- Growth of microbiome-modified mouse models to investigate gut-brain axis interactions in neurodegenerative research
- Rising demand for aged mouse models to better mirror geriatric disease phenotypes in cardiovascular research
- Utilization of high-throughput phenotyping platforms for large-scale mouse genetic screening in precision medicine
- Integration of artificial intelligence-driven image analysis in mouse behavioral assays for neuropsychiatric drug discovery
- Development of ultra-flexible custom breeding programs for transgenic and knockout mouse lines to meet specialized research needs
The companies profiled in this Mice Model market report include:
- Applied StemCell, Inc.
- Aragen Life Sciences Ltd.
- Biocytogen Boston Corporation
- Charles River Laboratories International, Inc.
- Creative Biolabs
- Crown Bioscience by JSR Life Sciences, LLC
- Cyagen US Inc. by PolyGene AG
- Envigo by Inotiv, Inc.
- GenOway
- Harbour BioMed
- inGenious Targeting Laboratory, Inc.
- Janvier Labs
- Marshall BioResources
- MD Biosciences
- Mirimus, Inc.
- Ozgene Pty Ltd.
- PhoenixBio Co., Ltd.
- Shanghai Model Organisms Center, Inc.
- Taconic Biosciences, Inc.
- The Jackson Laboratory
- TransCure bioServices
- Translational Drug Development, LLC
- Urosphere SAS
- XenOPAT SL by Bellvitge Biomedical Research Institute
For more information about this report visit https://www.researchandmarkets.com/r/rq79lz
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
